D 75N95022Q00483-CSS.pdf

COMBINED SYNOPSIS / SOLICITATION

75N95022Q00483

TITLE: AlphaLISA reagents for the Antiviral Program for Pandemics

THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS

SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING

FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).

The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to PerkinElmer Health Sciences Inc. (PerkinElmer), 710 Bridgeport Avenue Shelton, CT 06484-4794. Only the alphaLISA reagents will meet the Government’s need because only these reagents employ the singlet oxygen reaction method of detection to monitor this specific enzyme reaction. These alphaLISA reagents were developed by PerkinElmer and PerkinElmer is the only vendor who distributes them.

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice.

This announcement constitutes the only solicitation; quotations are being requested and a written solicitation will not be issued.

(ii) The solicitation number is 75N95022Q00483 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13 - Simplified Acquisition Procedures and FAR Part 12 - Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through

Federal Acquisition Circular (FAC) 2022-06 effective May 26, 2022.

(iv) The associated NAICS code is 325413 and the Small Business size standard is 1,250 employees. This requirement is non-competitive and no set-aside restrictions are applicable.

DESCRIPTION

(v) The National Center for Advancing Translational Sciences (NCATS), within the National

Institutes of Health (NIH), requires AlphaLISA reagents for the Antiviral Program for Pandemics (APP). The specific reagents include:

QTY (1) 50mgs of SA-Donor beads QTY (1) 25mgs of anti-DIG Acceptor beads QTY (2) 10,000 tests TruHits

(vi) The anticipated delivery date is four (4) weeks after receipt of order. Quoters may propose an alternative delivery date.

Delivery shall be made to Rockville, MD, FOB Destination. The exact address will be noted on the purchase order.

EVALUATION AND AWARD

(vii) The anticipated award date is August 19, 2022.

(viii) The Government plans to make a firm fixed-price award resulting from this solicitation. The resulting award will be made to PerkinElmer Health Sciences Inc. as long as it is technically capable and agrees to a fair and reasonable price. If additional quotations are received, the Government will make an award to the vendor who represents the best value to the Government. The best value will be determined by using a trade-off approach and comparative evaluations in consideration of the following evaluation criteria:

1. Technical Capability: The ability to provide the required reagents, and the proposed delivery date.

2. Past Performance: Past performance providing similar supplies. The Government may use any source of available past performance information (see FAR 13.106-2(b)(3)).

3. Price: The total price.

SUBMISSION INSTRUCTIONS

(ix) All responses to this RFQ must be received by 9:00am Eastern Time on August 12, 2022 and must reference the solicitation number cited above. Responses must be submitted via email to Kimberly Espinosa at kimberly.espinosa@nih.gov.

(x) This is an RFQ. This request does not commit the Government to pay any costs incurred in the preparation of the submission of this quotation or to contract for supplies or service.

Supplies are of domestic origin unless otherwise indicated by quoter. Any representations and/or certifications attached to this RFQ must be completed by the quoter.

(xi) Responses to this RFQ must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. Responses may exceed capability or performance characteristics of the solicitation's requirements. The Government reserves the right, but is not required, to award to a response that exceeds capability or performance characteristics of the solicitation's requirements if it provides a benefit to the Government.

(xii) Responses must also include the Unique Entity Identifier (UEI) (which recently replaced the

DUNS number), the Taxpayer Identification Number (TIN), the certification of business size, the completed representation in FAR Provision 52.225-2 (attached), and a quotation that mailto:kimberly.espinosa@nih.gov includes:

1. The total price,

2. Individual prices for each item,

3. The delivery date. Respondents shall confirm their ability to deliver the items without four

(4) weeks after receipt of order or propose an alternative delivery date.

4. Prompt payment discount terms,

5. Product or catalog number(s),

6. Product description, and

7. Any other information or factors that may be considered in the award decision. Such factors may include: special features required for effective program performance; trade-in considerations; warranty considerations; maintenance availability; and environmental and energy efficiency considerations.

(xiii) For information about this RFQ, contact Kimberly Espinosa, Contracting Officer, at 301-827-

3546 or kimberly.espinosa@nih.gov.

(xiv) All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.

TERMS AND CONDITIONS, PROVISIONS, AND REPRESENTATIONS

(xv) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb

1998). This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at www.acquisition.gov.

The following provisions apply to this acquisition and are incorporated by reference:

1. FAR Provision 52.204-7, System for Award Management (Oct 2018)

2. FAR Provision 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020)

3. FAR Provision 52.212-3, Offeror Representations and Certifications—Commercial Products and Commercial Services (Nov 2021)

(xvi) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998). This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at www.acquisition.gov.

In addition to the clauses checked in FAR 52.212-5 (attached), the following clauses also apply to this acquisition and are incorporated by reference:

1. FAR Clause 52.204-13, System for Award Management Maintenance (Oct 2018)

2. FAR Clause 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020)

3. FAR Clause 52.212-4, Contract Terms and Conditions – Commercial Products and

Commercial Services (Nov 2021)

4. HHSAR Clause 352.222-70, Contractor Cooperation in Equal Employment Opportunity

Investigations (December 18, 2015)

(xvii) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement.

(xviii) HHS reserves the right to exercise priorities and allocations authority with respect to this contract, to include rating this order in accordance with 45 CFR Part 101, Subpart A - Health Resources Priorities and Allocations System.

ATTACHMENTS

(xix) The following terms, provisions, and clauses are incorporated and attached in full text:

1. The provision at FAR 52.212-1, Instructions to Offerors – Commercial Products and Commercial Services (Nov 2021) (Tailored)

2. FAR Provision 52.225-2, Buy American Certificate (Feb 2021)

3. The clause at FAR 52.212-5, Contract Terms and Conditions Required to Implement

Statutes or Executive Orders–Commercial Products and Commercial Services (Jan 2022)

4. NIH Electronic Invoice Submission Instructions with IPP (April 21, 2022)